Natan Ponieman - Spark Newswire

3 minute read

Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial

Today, 2:40 PM

A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials,…

NMDBF

2 minute read

Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy

By Natan Ponieman

Today, 2:40 PM

Michael Mullette, a former Moderna (NASDAQ:MNRA) vice president is taking a senior leadership position in the MAPS Public Benefit…

MNRA

4 minute read

Psyched: First Australian Psych Company On Nasdaq, Utah’s Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results

By Natan Ponieman

Today, 2:40 PM

On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of…

CSE:LUV

2 minute read

LSD And Magic Mushroom’s Active Compound Appear To Have The Same Effects, New Study Finds

By Natan Ponieman

Today, 2:40 PM

A new peer-reviewed study compared the effects of LSD and psilocybin, two substances currently standing as top molecules…

MNMD

2 minute read

Researcher Portrayed In Hollywood Movie By Alec Baldwin Joins Psychedelics Company

By Natan Ponieman

Today, 2:40 PM

In 2015, the movie â€‹â€‹Concussion, starring Will Smith and Alec Baldwin, told the true story of a doctor and his fight…

BWVI

6 minute read

Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study

By Natan Ponieman

Today, 2:40 PM

Psilocybin received yet another confirmation of its beneficial effects in the treatment of major depressive disorder, this time, in the long term. A new Johns Hopkins review study found that the positive effects of just two sessions of psilocybin-assisted psychotherapy can last for over one year in most patients with depression.

CYBN

1 minute read

Psilocybin For Cancer Related Distress: Enveric To Launch Clinical Trial In Partnership With University of Calgary

By Natan Ponieman

Today, 2:40 PM

Enveric Biosciences (NASDAQ: ENVB) a neuroscience company developing psychedelics and cannabinoids into mental health medicines, announced a collaboration with the University of Calgary’s Hotchkiss Brain Institute.

ENVB

2 minute read

Magic Mushroom’s Active Compound Could Relieve Depression For Up To One Year, New Study Finds

By Natan Ponieman

Today, 2:40 PM

A new review study by Johns Hopkins University researchers is shedding light on the long-term effects of psilocybin in the treatment of major depression. In a new study, 58% of participants with major depressive disorder were in remission after one year of doing two sessions with psilocybin.

CMPS

1 minute read

Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education

By Natan Ponieman

Today, 2:40 PM

Psychedelics-focused biotech company Cybin Inc. (NYSE: CYBN) announced that it has formed a partnership with The Chopra Foundation, a not-for-profit founded by alternative medicine and new age author Deepak Chopra.

CYBN

5 minute read

Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins

By Natan Ponieman

Today, 2:40 PM

The Week in Psychedelics

CYBN